Chris H. Takimoto, Chief Medical Officer at IGM Biosciences, Inc. (IGMS), sold 1,180 shares at $6.21 ($7K) on 2023-11-29, disclosed to the SEC on 2023-12-01.
Open-market sale of $7k IGMS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2024-03-15 | $54K | — | Filing → |
| IGMS | SELL | 2023-05-25 | $15K | — | Filing → |
| IGMS | SELL | 2023-03-16 | $33K | — | Filing → |